European cost-effectiveness analysis of cervical screening strategies for women not vaccinated for HPV: in many scenarios primary HPV screening is preferable to primary cytology screening in women aged over 30 years
- PMID: 23024211
- DOI: 10.1136/eb-2012-100774
European cost-effectiveness analysis of cervical screening strategies for women not vaccinated for HPV: in many scenarios primary HPV screening is preferable to primary cytology screening in women aged over 30 years
Comment on
-
Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model.BMJ. 2012 Mar 5;344:e670. doi: 10.1136/bmj.e670. BMJ. 2012. PMID: 22391612 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources